Drug Shortage Report for TEVA-SALBUTAMOL HFA
| Report ID | 105599 |
| Drug Identification Number | 02326450 |
| Brand name | TEVA-SALBUTAMOL HFA |
| Common or Proper name | SALBUTAMOL 100MCG HFA INHALER |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | SALBUTAMOL |
| Strength(s) | 100MCG |
| Dosage form(s) | METERED-DOSE AEROSOL |
| Route of administration | INHALATION |
| Packaging size | 200 dose |
| ATC code | R03AC |
| ATC description | ADRENERGICS, INHALANTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2020-02-07 |
| Estimated end date | 2020-07-31 |
| Actual end date | 2020-07-29 |
| Shortage status | Resolved |
| Updated date | 2020-07-30 |
| Company comments | Teva Allocating to 70% of the generic market. Increased demand experienced. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v21 | 2020-07-30 | French | Compare |
| v20 | 2020-07-30 | English | Compare |
| v19 | 2020-06-25 | French | Compare |
| v18 | 2020-06-25 | English | Compare |
| v17 | 2020-05-29 | French | Compare |
| v16 | 2020-05-29 | English | Compare |
| v15 | 2020-05-01 | French | Compare |
| v14 | 2020-05-01 | English | Compare |
| v13 | 2020-04-03 | French | Compare |
| v12 | 2020-04-03 | English | Compare |
| v11 | 2020-04-03 | French | Compare |
| v10 | 2020-04-03 | English | Compare |
| v9 | 2020-04-03 | French | Compare |
| v8 | 2020-04-03 | English | Compare |
| v7 | 2020-03-23 | English | Compare |
| v6 | 2020-03-23 | English | Compare |
| v5 | 2020-03-18 | French | Compare |
| v4 | 2020-03-18 | English | Compare |
| v3 | 2020-02-08 | English | Compare |
| v2 | 2020-02-07 | French | Compare |